Keyword Analysis & Research: sanofi immunology pipeline
Keyword Research: People who searched sanofi immunology pipeline also searched
Search Results related to sanofi immunology pipeline on Search Engine
-
Sanofi Pipeline - Sanofi
https://www.sanofi.com/en/science-and-innovation/research-and-development/rd-pipeline
WebSep 30, 2022 · Our Pipeline. Our determination to find answers for patients and their …
DA: 3 PA: 45 MOZ Rank: 74
-
Immunology - Sanofi
https://www.sanofi.com/en/your-health/specialty-care/immunology
WebSanofi’s portfolio of medicines includes the first biologic treatment approved for people …
DA: 56 PA: 47 MOZ Rank: 85
-
Sanofi Ups Immunology Game With $1.4 Billion …
https://www.biospace.com/article/sanofi-boosts-immunology-pipeline-with-1-4-billion-acquisition-of-kymab/
WebJan 11, 2021 · French pharma giant Sanofi kicks off 2021 with a $1.4 billion cash acquisition of U.K.-based Kymab to bolster the company’s …
DA: 6 PA: 43 MOZ Rank: 17
-
Sanofi kicks off new immunology research journey with …
https://www.fiercebiotech.com/biotech/sanofi-kicks-off-new-immunology-drug-discovery-journey-stanford-pact
WebSanofi kicks off new immunology research journey with Stanford pact | Fierce Biotech. Fierce Pharma. Fierce Biotech. Fierce Healthcare. Fierce Life Sciences Events. Research. Biotech. Medtech. CRO.
DA: 72 PA: 1 MOZ Rank: 57
-
Head of Exploratory Research, Type 2 Immunology at Sanofi
https://jobs.sanofi.us/job/cambridge/head-of-exploratory-research-type-2-immunology/507/43922827952
WebSanofi is a leader in type 2 immunology with a robust pipeline of approved and …
DA: 49 PA: 74 MOZ Rank: 25
-
JPM 2022: Sanofi has designs on creating Big Pharma's 'strongest
https://www.fiercepharma.com/pharma/sanofi-aims-to-create-big-pharma-s-strongest-immunology-franchise-cfo-says
WebSanofi has been no stranger to the biopharma dealmaking circuit under CEO Paul …
DA: 54 PA: 4 MOZ Rank: 83
-
Sanofi (SNY) to Acquire Kymab to Boost Immunology Presence
https://www.nasdaq.com/articles/sanofi-sny-to-acquire-kymab-to-boost-immunology-presence-2021-01-11
WebJan 11, 2021 · Sanofi SNY announced an agreement to acquire Kymab, a small biotech …
DA: 46 PA: 84 MOZ Rank: 70
-
Sanofi starts off 'pipeline-in-a-product' rilzabrutinib in rare skin
https://www.fiercebiotech.com/biotech/sanofi-starts-off-pipeline-a-product-rilzabrutinib-rare-skin-disease-but-eyes-bigger
WebSanofi starts off 'pipeline-in-a-product' rilzabrutinib in rare skin disease, but eyes bigger …
DA: 23 PA: 34 MOZ Rank: 81
-
Sanofi in the News: Grand Expectations and Paul Hudson's $12
https://www.biospace.com/article/sanofi-in-the-news-ceo-compensation-bonds-and-igm-deal/
WebMar 31, 2022 · Sanofi also reported its annual sales, emphasizing Dupixent (dupilumab) …
DA: 15 PA: 20 MOZ Rank: 100
-
Sanofi (SNY) Acquires Tidal to Aid mRNA-Based Research Platform
https://www.nasdaq.com/articles/sanofi-sny-acquires-tidal-to-aid-mrna-based-research-platform-2021-04-12
WebApr 12, 2021 · Sanofi SNY announced that it has acquired Cambridge, MA-based …
DA: 16 PA: 24 MOZ Rank: 15
